The differential coregulator milieu within breast tumors and the dependence of breast tumors on ER and coregulator-driven signaling may explain why ERX-11 has potent antiproliferative activity within the tumor but does not have any overt signs of toxicity. Here, ESR1 is linked to breast neoplasm.